IE
CARL

Israel Englander’s Carlsmed CARL Stock Holding History

Israel Englander’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Buy
+295,907
New +$3.11M ﹤0.01% 3447
2026
Q1 		– Sell
-128,970
Closed -$1.59M – 6571
2025
Q4 		$1.59M Buy
128,970
+108,208
+521% +$1.44M ﹤0.01% 4135
2025
Q3 		$278K Buy
+20,762
New +$284K ﹤0.01% 5369

Other funds holding CARL

JT
Jupiter Topco New York $245B AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KC
KCM Capital Shawnee, Kansas $618M AUM
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Israel Englander's CARL Position: Q2 2026 in Review

Israel Englander opened a new position in Carlsmed (CARL) in Q2 2026: 295,907 shares worth $3.07M. The stake represents ﹤0.01% of the portfolio and ranks #3447 among its holdings. This is a return to the name: Israel Englander previously reported a position in CARL as recently as Q4 2025.

Israel Englander first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • Israel Englander held 295,907 shares of Carlsmed worth $3.07M as of Q2 2026.
  • Carlsmed was a new Israel Englander position in Q2 2026.
  • Carlsmed made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3447 holding.
  • Israel Englander first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.